ACE Inhibition Modulates Myeloid Hematopoiesis after Acute Myocardial Infarction and Reduces Cardiac and Vascular Inflammation in Ischemic Heart Failure

Aims: Angiotensin-converting-enzyme inhibitors (ACE inhibitors) are a cornerstone of drug therapy after myocardial infarction (MI) and improve left ventricular function and survival. We aimed to elucidate the impact of early treatment with the ACE inhibitor ramipril on the hematopoietic response aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudi, Wolf-Stephan, Molitor, Michael, Garlapati, Venkata, Finger, Stefanie, Wild, Johannes, Münzel, Thomas, Karbach, Susanne H., Wenzel, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001011/
https://www.ncbi.nlm.nih.gov/pubmed/33807982
http://dx.doi.org/10.3390/antiox10030396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001011/
https://www.ncbi.nlm.nih.gov/pubmed/33807982
http://dx.doi.org/10.3390/antiox10030396

Ejemplares similares